SU6668 in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of SU6668 in treating patients who have advanced
solid tumors. SU6668 may stop the growth of solid tumors by stopping blood flow to the tumor